← Leaderboards
Amod Sarnaik
H. Lee Moffitt Cancer Ctr & Res Inst
$826,070
Attributed
$826,070
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $187.6K · FY2013–17$200K$150K$100K$50K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$826,070 · 1
By mechanism
K23$826,070 · 1
Top collaborators
No co-investigators on record.
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- Jose R Conejo-Garcia$21,497,732
- Frederick Locke$1,743,048
- Eric B. Haura$11,744,471
- Lauren Cole Peres$4,649,275
- Shari Pilon-Thomas$5,168,533
Others in their field
Top investigators on “Combined Modality Therapy”
- Charles A Coltman · Southwest Oncology Group$152,345,696
- Philip J Disaia · University Of California Irvine$115,623,751
- Walter John Curran · Thomas Jefferson University$70,626,214
- Randall J Bateman · Washington University$64,707,456
- Richard L Schilsky · University Of Chicago$50,043,295
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$46,323,713
Research focus
Combined Modality TherapyDesignAntibodiesAdoptive TransferAdvisory CommitteesAdoptive Cell TransfersBiometryBlocking AntibodiesCancer CenterBaseCareer DevelopmentCaringCell PhysiologyCell SurfaceCell TherapyCellular BiologyCessation Of LifeChemotherapyClinical PharmacologyClinical ResearchClinical TrialsCareerCohortDevelopment Plans
Grant awards (5)
Co-Stimulation to Enhance Adoptive Cell Therapy for Metastatic Melanoma$75,778
K23 · FY2017 · CA · contact PI
Co-Stimulation to Enhance Adoptive Cell Therapy for Metastatic Melanoma$187,573
K23 · FY2016 · CA · contact PI
Co-Stimulation to Enhance Adoptive Cell Therapy for Metastatic Melanoma$187,573
K23 · FY2015 · CA · contact PI
Co-Stimulation to Enhance Adoptive Cell Therapy for Metastatic Melanoma$187,573
K23 · FY2014 · CA · contact PI
Co-Stimulation to Enhance Adoptive Cell Therapy for Metastatic Melanoma$187,573
K23 · FY2013 · CA · contact PI